Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Amortizatization of Intangibles (2020 - 2021)

Design Therapeutics' Amortizatization of Intangibles history spans 2 years, with the latest figure at $14000.0 for Q4 2021.

  • For Q4 2021, Amortizatization of Intangibles rose 600.0% year-over-year to $14000.0; the TTM value through Dec 2021 reached $19000.0, down 73.24%, while the annual FY2025 figure was $3.3 million, 47.52% down from the prior year.
  • Amortizatization of Intangibles for Q4 2021 was $14000.0 at Design Therapeutics, up from -$123000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $150000.0 in Q1 2021 and bottomed at -$123000.0 in Q3 2021.